Still the status quo for painful diabetic neuropathy

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1593, 2007-01, pp. : 18-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Desipramine, duloxetine best bets in painful diabetic neuropathy

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 568, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Therapeutic potential of PKC inhibitors in painful diabetic neuropathy

By Kamei Junzo   Mizoguchi Hirokazu   Narita Minoru   Tseng Leon F  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 9, 2001-09 ,pp. : 1653-1664

Informa Healthcare

Access to resources Recommend Favorite

Diabetic Painful Neuropathy: Current and Future Treatment Options

By Chong M. Sam   Hester Joan  

Drugs, Vol. 67, Iss. 4, 2007-01 ,pp. : 569-585

Adis International

Access to resources Recommend Favorite

Pregabalin: In the Treatment of Painful Diabetic Peripheral Neuropathy

By Frampton James E.   Scott Lesley J.  

Drugs, Vol. 64, Iss. 24, 2004-01 ,pp. : 2813-2820

Adis International

Access to resources Recommend Favorite

Aldose Reductase, Still a Compelling Target for Diabetic Neuropathy

By  

Current Drug Targets, Vol. 9, Iss. 1, 2008-01 ,pp. : 14-36

Bentham Science Publishers

Access to resources Recommend Favorite